Revenue Growth
Q1 revenue of $323.0M vs $277.0M in Q1 2025, an increase of approximately 16.6%, driven by new investments, annual escalators, and active portfolio management.
Omega Healthcare
· OHI
April 28th, 2026
Summary
- Earnings Call Date:
- 2026-04-28
- Change Since:
- +1.37%
- Next Earnings Date:
- 2026-08-03
Earnings Call Sentiment
PositiveThe call presented a broadly positive operating and financial picture: strong top‑line and adjusted cash flow growth (revenue +16.6% YoY, net income and EPS up materially, FAD per share +9.5%), tightened guidance with an increased midpoint, active and accretive deployment of capital, a sizeable $480M strategic sale to redeploy into higher-yielding opportunities, and a healthy liquidity and leverage profile. Offsetting items include bankruptcy exposure to Genesis, short‑term noise from asset sales and loan repayments that slightly reduced AFFO, issuance-related dilution, a competitive acquisition market with cap‑rate compression, occupancy stagnation in the near term, and reimbursement/legal risks that require monitoring. On balance, the positive operational and financial momentum, reinforced guidance, and strong balance sheet materially outweigh the risks discussed on the call.
Company Guidance
Omega narrowed full‑year adjusted AFFO guidance to $3.19–$3.25 per share (midpoint $3.22, up $0.02), with Q1 AFFO of $0.82 and FAD of $0.78 per share; the company noted dividend payout ratios of 82% (AFFO) and 86% (FAD) and expects the $480 million CommuniCare sale proceeds to produce roughly $0.03 of annual AFFO/FAD accretion once redeployed. Guidance reflects investments closed through April 27, assumes $65 million of the $159 million of mortgages maturing in 2026 will convert to fee simple (the balance repaid), expects $224 million of non‑real‑estate loans (including ≈$159.5 million of Genesis loans) to be repaid in 2026, and factors Q1 rent on the sold facilities of $9.2 million; it excludes additional investments or capital transactions beyond those disclosed. The company cited supporting balance‑sheet metrics: $425 million drawn on the revolver, $26 million of cash plus the ~$480 million assets‑held‑for‑sale, >$1.5 billion available on a $2.0 billion revolver, next debt maturity April 2027, fixed‑charge coverage of 6.3x and leverage of 3.5x.
Earnings and Cash Flow Strength
Net income of $159M ($0.47/share) vs $112M ($0.33/share) in prior year, a ~42.4% increase in EPS; adjusted FFO of $260M ($0.82/share) and FAD of $247M ($0.78/share). AFFO and FAD per share were $0.02 higher than Q4.
FAD Per Share and Dividend Payout Improvement
FAD per share increased 9.5% year-over-year. Dividend payout ratios decreased to 82% of AFFO and 86% of FAD, indicating improved coverage and potential room for future dividend discussions.
Tightened and Upward Guidance
Full-year adjusted AFFO guidance narrowed to $3.19–$3.25 per share with the midpoint increased to $3.22 (midpoint up $0.02 from prior guidance), reflecting management confidence in cash flow trajectory.
Active Portfolio Management and Cash Recycling
Strategic sale of 18 CommuniCare assets for $480M (12 sold post-quarter) with expected redeployment to generate ~ $0.03 of annual AFFO/FAD accretion; Q4+Q1 produced $585M in new investments contributing incremental net income.
Robust Investment Activity and Attractive Yields
YTD transaction activity of $326M and $251M completed new investments (plus $13M CapEx); weighted average yield on leases/loans of 10.9%; subsequent post-quarter closings of $75M (two IN SNFs $33M at 10% lease yield and three RI SHOP $42M RIDEA).
Strong Liquidity and Balance Sheet
At 3/31: $425M drawn on revolver, ~$26M cash, assets held for sale expected to raise ~$480M, and >$1.5B available capacity on $2.0B revolver. Fixed charge coverage 6.3x and leverage stable at 3.5x with next maturity in April 2027.
Pipeline and RIDEA Expansion
Growing pipeline across U.S. and UK with focus on senior housing RIDEA, skilled nursing and UK care homes; management pursuing mid-teens IRRs and building teams/boots-on-ground for sourcing and asset management (UK presence ramped up).
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Omega Healthcare Investors, Inc. First Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star 1 again. Thank you.
I will now turn the conference over to Michele Reber. You may begin.
Michele Reber
Thank you, and good morning. With me today is Omega CEO, C. Taylor Pickett, President, Matthew P. Gourmand, CFO, Robert O. Stephenson, CIO, Vikas Gupta, and Megan M. Krull, Senior Vice President, Data Intelligence and Government Relations. Comments made during this conference call that are not historical facts may be forward-looking statements, such as statements regarding our financial projections, potential transactions, operator prospects, and outlook generally. Factors that could cause actual results to differ materially from those in the forward-looking statements are detailed in the company’s filings with the SEC.
During the call today, we will refer to some non-GAAP financial measures, such as NAREIT FFO, adjusted FFO, FAD, and EBITDA. Reconciliations of these non-GAAP measures to the most comparable measure under generally accepted accounting principles are available in the quarterly supplement. In addition, certain operator coverage and financial information that we discuss is based on data provided by our operators that has not b...
Subscribe to unlock transcripts
Get The Fly Pro 7 days for free